Jake Carney was named Chief Financial Officer of Exascale Labs Holdings Inc., succeeding Gildas Bonnier, effective September 25, 2026. As of November 6, 2026, Exascale Labs Holdings Inc. has reported 2 leadership change filings to the SEC under Item 5.02 of Form 8-K, from September 8, 2026 to September 30, 2026, naming 2 appointments and 1 departure (Form 8-K, September 30, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like Exascale Labs Holdings Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Exascale Labs Holdings Inc. reported changes in 2 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-09-08 to 2026-09-30. They name 2 people, with 2 appointments and 1 departure. Every row below is cited to the filing it comes from, and this page adds each new change as Exascale Labs Holdings Inc. files it.
Also on the record for Exascale Labs Holdings Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| October 29, 2026 | Stake report, Schedule 13G, by Hack Seed Fund II LP | 5.9% of the class | 5%+ stakes | Source |
| October 15, 2026 | Stake report, Schedule 13G, by ARC Group International Limited | 14.7% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs Exascale Labs Holdings Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on Exascale Labs Holdings Inc. and the records around it.
Exascale Labs Holdings Inc. elsewhere on the record
- 5%+ stake filings Oct 2026
- Who owns it
Companies that share a holder
- ARC Group International Limited also filed stake reports on 1 other company: Abits Group Inc (Sep 2026)
Watch Exascale Labs Holdings Inc.
Get an email when Exascale Labs Holdings Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Exascale Labs Holdings Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Exascale Labs Holdings Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Exascale Labs Holdings Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
4 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-09-30 | Out | Chief Financial Officer | 2026-09-25 | 8-K, 2026-09-30 | |
| 2026-09-30 | In | Chief Financial Officer | 2026-09-25 | 8-K, 2026-09-30 | |
| 2026-09-08 | In | Chief Financial Officer | 2026-09-04 | 8-K, 2026-09-08 |
Who leads Exascale Labs Holdings Inc., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Chief Financial Officer: Gildas Bonnier, departure reported, effective 2026-09-25 (filed 2026-09-30). No successor is named in these filings.
New leaders reset buying decisions — get the Full Report on Exascale Labs Holdings Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Chief Financial Officer at Exascale Labs Holdings Inc., with the record behind each one.
Find candidates like Chief Financial Officer at Exascale Labs Holdings Inc.Every change, in the filing's words
Departing: Gildas Bonnier, Chief Financial Officer, effective 2026-09-25
Effective September 25, 2026, Gildas Bonnier ceased serving as the Interim Chief Financial Officer of Exascale Labs Holdings Inc. (the "Company").
Appointed: Jake Carney, Chief Financial Officer, effective 2026-09-25
The Company has completed that search process and, as described below, has appointed Jake Carney as the Company's Chief Financial Officer, effective September 25, 2026.
- As previously reported, Mr. Bonnier was appointed as the Company's Interim Chief Financial Officer while the Company conducted a formal search process to identify and appoint a permanent Chief Financial Officer of the Company.
- Accordingly, Mr. Bonnier's interim service as Chief Financial Officer is no longer required.
- Mr. Bonnier's departure from the position of Interim Chief Financial Officer of the Company was not the result of any disagreement with the Company relating to the Company's operations, policies or practices.
- Appointment of Chief Financial Officer Effective September 25, 2026, the board of directors of the Company appointed Jake Carney to serve as the Company's Chief Financial Officer.
- Jake Carney, 38, is an investment professional with 15 years of experience across banking, investment advisory and fintech environments.
- Mr. Carney has served as Chief Financial Officer of ARC Group Securities Acquisition I, a Nasdaq-listed special purpose acquisition company, and previously served as Chief Financial Officer of Deal Flow Capital, a capital advisory firm, from February 2026 to August 2026.
- From June 2025 to July 2026, Mr. Carney worked in in-house fundraising and consulting roles for several companies.
- From September 2022 to April 2025, Mr. Carney served as Managing Director at ARC Group Limited, where he established and led the company's United Arab Emirates office.
Appointed: Gildas Bonnier, Chief Financial Officer, effective 2026-09-04
On September 4, 2026, Exascale Labs Holdings Inc. (the "Company") appointed Gildas Bonnier as Interim Chief Financial Officer of the Company, effective as of September 4, 2026.
- In his position as Interim Chief Financial Officer, Mr. Bonnier will act as the Company's "principal financial officer" while a formal search process to identify and appoint a permanent Chief Financial Officer of the Company is conducted.
- Mr. Bonnier will be reporting to the Chief Executive Officer of the Company and will be subject to the oversight of the Audit Committee of the Board of Directors of the Company.
- Gildas Bonnier, 51, has more than 20 years of experience in P&L oversight, strategic planning, margin improvement, cost optimization, and execution in capital-intensive businesses in the industrial infrastructure sector.
- From 2003 to 2024, Mr. Bonnier held progressively senior roles at Air Liquide.
- As Business Development Director, Hydrogen Energy (2021-2024), Mr. Bonnier managed commercial opportunities representing a substantial portion of business-unit revenue and gross margin and developed partnerships involving approximately $325 million of contemplated capital investment.
- As Data Science Group Lead, R&D (2017-2020), Mr. Bonnier led pricing, contract-optimization and customer analytics initiatives.
Tools for this story
Each opens in a new tab, filled in for Exascale Labs Holdings Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.